The modern CR and DR imaging systems are revolutionising radiology practice worldwide. According to you, how will its growing acceptability transform Indian radiology practice?
 |
| Suhas Pokale |
CR and DR imaging systems are certainly well accepted by radiologists, physicians and also by patients. In fact, these systems have brought in great deal of convenience, speed and accuracy for basic X-ray imaging. Though Indian radiology practice is looking forward to new, state-of-the-art, imaging modalities such as MRI, CT and PET, there are very large numbers of basic X-ray procedures done every day. The diagnosis of these in the shortest time without having to repeat has been facilitated by these modalities. Further, these images can now be stored in digital format on computer and also can be sent to referring physician or surgeon instantly.
How has the year 2012 been for FUJIFILM in India? Also tell us how has Fuji’s FDR range of products performed in the Indian market?
FUJIFILM in India has experienced further growth of CR systems sales. This growth has been more in Tier II and Tier III towns. Since the launch of FDR, we have installed over 50 systems in India. Year 2012 has been a major contributor in DR installations growth. Many of our customers who have switched from CR to DR, are very excited to have the product with better quality and also high speed.
What are you showcasing at the forthcoming IRIA 2013 in Indore? How promising is this event for Fuji India?
We are showcasing the complete range of FDR DEVO panels which help to convert existing X-ray system to FUJI DR system. Our new wireless DR panel of small size can be used in spot film devices. Our SYNAPSE PACS solutions with latest version along with the new SYNAPSE 3D is also being displayed. We are also displaying our new CR system and imager products. Ultrasound equipment from Sonosite (FUJIFILM Company) also will displayed.
Do you see good potential in Tier II markets for your business growth? Which imaging products will have demand in such market sin particular?
We are currently witnessing more growth in Tier II markets. Our CR systems in particular are in more demand in these markets. As these Tier II markets print images, most of the CR systems are sold with imagers.
Tell us about the growing acceptability and convenience of ITisation in post image processing. How has your PACS product- Synapse benefitted radiologists in their day to day practice?
Though most of the radiology images are printed on films, we are observing large hospitals, and especially new ones, are considering PACS solutions in order to become paperless and filmless. Many hospitals are adopting new IT solutions for better workflow. SYNAPSE PACS has provided many radiologist tools for fast and accurate diagnosis and also convenience to report the images remotely across the globe. SYNAPSE 3D gives excellent tools of on the fly reconstruction of the images from the basic image data received through various modalities.
On which other imaging modalities will Fuji focus in near future?
CR, DR, mobile digital solutions, mammography and PACS are modalities we continue to focus.
Does Fuji have any future plans for strategic alliance or acquisitions in near future?
Healthcare is one of the key businesses for FUJIFILM Corporation. We continue to develop new products with the core technology that we have.
- Advertisement -
